• Dolutegravir Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, Polymorphically Stabilized Microdose Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or Alu-Alu blister strips to ensure the absolute chemical survival of the Dolutegravir Sodium salt.

    Active IngredientStrengthPrimary Clinical Function
    Dolutegravir (as Sodium) USP/Ph.Eur.50 mgThe Global INSTI Anchor: The definitive therapeutic payload required to force immediate, systemic viral suppression and maintain an undetectable viral load.
    ExcipientsD-Mannitol / Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone K-30 / Sodium Stearyl Fumarate / Premium Polymeric FilmDiluent / Binder / Superdisintegrant / Glidant / Heavy Film-Coating (Engineered specifically utilizing strict low-moisture granulation to prevent the active Dolutegravir Sodium from undergoing polymorphic shifts during compression, guaranteeing absolute pharmacokinetic bioequivalence)

    *Pack Sizes: Heavy-Gauge HDPE Bottles of 30 or 10×10 Alu-Alu Blisters (Optimized specifically for massive NGO distribution and chronic daily dispensing regimens).

  • Efavirenz ,Emtricitabine & Tenofovir Disoproxil Fumarate Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, Hydrolytically Shielded Mega-Dose FDC Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles to ensure the absolute chemical survival of the moisture-sensitive Tenofovir and light-sensitive Efavirenz.

    Active IngredientStrengthPrimary Clinical Function
    Efavirenz USP/Ph.Eur.600 mgThe NNRTI Anchor: The massive, highly lipophilic non-nucleoside payload required to force immediate, systemic viral suppression.
    Emtricitabine (FTC) USP/Ph.Eur.200 mgThe Cytidine Analogue: Provides profound, long-acting intracellular viral suppression to reinforce the backbone.
    Tenofovir Disoproxil Fumarate (TDF) USP/Ph.Eur.300 mgThe Nucleotide Backbone: The heavy-hitting chain terminator required to completely halt viral DNA elongation.
    ExcipientsMicrocrystalline Cellulose / Croscarmellose Sodium / Hydroxypropyl Cellulose / Sodium Lauryl Sulfate / Magnesium Stearate / Premium Polymeric FilmDiluent / Superdisintegrant / Binder / Surfactant / Heavy Film-Coating (Engineered utilizing High-Compression Bi-Layer Technology to fuse 1,100mg of active API into a single, aerodynamically shaped tablet that remains easy for patients to swallow, heavily coated to lock out destructive tropical humidity)

    *Pack Sizes: Heavy-Gauge HDPE Bottles of 30 (Optimized specifically for massive NGO distribution and strict 30-day chronic daily dispensing regimens).

  • Efavirenz Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, High-Density Macrodose Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or Alu-Alu blister strips to ensure the absolute chemical survival of the highly lipophilic active ingredient.

    Active IngredientStrengthPrimary Clinical Function
    Efavirenz USP/Ph.Eur.600 mgThe Global NNRTI Macrodose: The massive therapeutic payload required to force immediate, systemic viral suppression when combined with a dual-NRTI backbone.
    ExcipientsMicrocrystalline Cellulose / Croscarmellose Sodium / Sodium Lauryl Sulfate / Povidone K-30 / Magnesium Stearate / Premium Polymeric FilmDiluent / Superdisintegrant / Surfactant / Binder / Heavy Film-Coating (Engineered specifically utilizing powerful surfactants like Sodium Lauryl Sulfate to drastically increase the solubility of the notoriously lipophilic Efavirenz molecule, ensuring rapid and complete gastrointestinal absorption)

    *Pack Sizes: Heavy-Gauge HDPE Bottles of 30 or 10×10 Alu-Alu Blisters (Optimized specifically for massive NGO distribution and chronic daily dispensing regimens).

  • Emtricitabine & Tenofovir Disoproxil Fumarate Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, Hydrolytically Shielded Macrodose FDC Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or Alu-Alu blister strips to ensure the absolute chemical survival of the moisture-sensitive Tenofovir.

    Active IngredientStrengthPrimary Clinical Function
    Emtricitabine (FTC) USP/Ph.Eur.200 mgThe Cytidine Analogue: Provides profound, long-acting intracellular viral suppression with an exceptionally favorable safety profile.
    Tenofovir Disoproxil Fumarate (TDF) USP/Ph.Eur.300 mg
    (Eq. to 245 mg Tenofovir Disoproxil)
    The Nucleotide Backbone: The heavy-hitting reverse transcriptase inhibitor required to anchor the ARV regimen and prevent viral breakthrough.
    ExcipientsMicrocrystalline Cellulose / Croscarmellose Sodium / Lactose Monohydrate / Magnesium Stearate / Premium Polymeric Film (Opadry)Diluent / Superdisintegrant / Binder / Lubricant / Heavy Film-Coating (Engineered specifically utilizing dry-granulation and heavy film-coating to protect the API from atmospheric moisture, ensuring the massive 500mg active payload remains structurally intact and easily swallowable)

    *Pack Sizes: Heavy-Gauge HDPE Bottles of 30 (Optimized specifically for massive NGO distribution and strict 30-day chronic daily dispensing regimens).

  • Indinavir sulphate Capsules

    Free

    Indinavir sulphate capsules contain the active antiviral drug and several inactive ingredients used to stabilize the medication for the treatment of HIV-1 infection.

  • Lamivudine & Zidovudine tablets

    Free

    Lamivudine Tablets IP 100 mg
    Each Filmcoated tablet contains :
    Lamivudine IP 100 mg exceipents Q.S.

    Lamivudine Tablets IP 150 mg
    Each Filmcoated tablet contains :
    Lamivudine IP 150 mg

    Lamivudine 150 mg + Zidovudine 300 mg + Nevirapine 200 mg tablets IP                                                                                                                                Each Film Coated Tablets Contains:                                                                                                                                                                                                      Lamivudine IP 150 mg                                                                                                                                                                                                                              Zidovudine IP 300 mg                                                                                                                                                                                                                            Nevirapine IP 200 mg                                                                                                                                                                                                                              Excipients Q.S.

    Lamuzy Tablets Lamivudine and Zidovudine Tablets IP
    Each Film Coated tablet contains :
    Zidovudine IP 300 mg
    Lamivudine IP 150 mg

    Cirolam 150 Tablets
    Lamivudine Tablets 150 mg
    Each Film Coated tablet contains :
    Lamivudine USP 150 mg

    Usage: – Hepatitis B infection

    Category: – HIV Anti Viral drugs

    Therapeutic category: – Antiviral, Anti HIV, Hepatitis Treatment

  • Nevirapine Tablets

    Free

    Nevirapine tablets IP 200 mg
    Each Film Coated Tablet Contains:
    Nevirapine IP 200 mg

    Usage: – Prevents human immunodeficiency virus (HIV)

    Category: – HIV Anti viral Drugs

    Therapeutic category: – Antiviral, Anti HIV

  • Tenofovir 300mg + Lamivudine 300mg +Dolutegravir 50mg tablets

    Free

    A fixed-dose combination tablet of Tenofovir (300mg) + Lamivudine (300mg) + Dolutegravir (50mg), often abbreviated as TLD, is a first-line antiretroviral therapy (ART) used to treat HIV-1 infection.